Daniel Steffens
Berlin, BE 12203, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.
Journal: Cells
Published: November 22, 2021
Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease.
Journal: Open heart
Published: January 05, 2021
PCSK9 inhibitors and cardiovascular outcomes.
Journal: Expert opinion on biological therapy
Published: October 09, 2019
Potassium-induced decrease in cytosolic Na+ alleviates deleterious effects of salt stress on wheat (Triticum aestivum L.).
Journal: Plant biology (Stuttgart, Germany)
Published: October 31, 2018
MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes.
Journal: Cardiovascular diabetology
Published: October 30, 2017
Incidence of MRI-detected brain lesions and neurocognitive function after electrical cardioversion in anticoagulated patients with persistent atrial fibrillation.
Journal: International journal of cardiology
Published: April 19, 2017
Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?
Journal: Thrombosis research
Published: October 16, 2016
Inhibition of platelet function with clopidogrel is associated with a reduction of inflammation in patients with peripheral artery disease.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: August 21, 2015
Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor.
Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: June 24, 2015
Last Updated: 09/26/2026